About Argus Cognitive
Argus Cognitive is a company based in Hanover (United States) founded in 2016 by Attila Meretei and Zoltan Toser. It operates as a SaaS (Software-as-a-Service) and HealthTech. Argus Cognitive offers products and services including Neurora, Neurora ASD, and Neurora SLP. Argus Cognitive operates in a competitive market with competitors including DOMO Health, HeartLab, PredictImmune, EMGuidance and Zhongzhi Daxin Technology, among others.
- Headquarter Hanover, United States
- Founders Attila Meretei, Zoltan Toser
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Argus Cognitive, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.1 M (USD), Grant
Sep 06, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Argus Cognitive
Argus Cognitive offers a comprehensive portfolio of products and services, including Neurora, Neurora ASD, and Neurora SLP.
Software for analyzing behavioral biometrics in patients.
Specialized software for autism spectrum disorder analysis.
Software focused on speech and language biometrics.
People of Argus Cognitive
Unlock access to complete
Unlock access to complete
Funding Insights of Argus Cognitive
Investors in Argus Cognitive
Argus Cognitive has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Argus Cognitive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Argus Cognitive
Investment portfolio details for Argus Cognitive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Argus Cognitive
Detailed financials for Argus Cognitive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Argus Cognitive Comparisons
Peer comparison for Argus Cognitive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Argus Cognitive
Argus Cognitive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DOMO Health, HeartLab, PredictImmune, EMGuidance and Zhongzhi Daxin Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud and AI-based data analysis tool for providers
|
|
| Locked | Locked | Locked |
Cloud-based echocardiography data analysis is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Web-based solution that provides access to relevant medicines information
|
|
| Locked | Locked | Locked |
AI solutions for surgical procedures and record management are provided.
|
|
| Locked | Locked | Locked |
Digital health diagnosis tools are provided for healthcare professionals.
|
Detailed competitors of Argus Cognitive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Argus Cognitive
Complete news archive for Argus Cognitive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Argus Cognitive
Argus Cognitive was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Argus Cognitive is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Zoltan Toser is the current CEO of Argus Cognitive. They have also founded this company.
Argus Cognitive is engaged in developing non-invasive technology for behavioral health analysis. The companys solutions are centered on automated video and audio analysis to provide comprehensive biometric reports for medical professionals. Operating in the healthcare sector, particularly in digital health, their flagship product Neurora is regulated as a medical device and delivered via a software-as-a-service model. Their technology supports clinical decisions by transforming qualitative data into actionable insights, primarily for conditions like autism spectrum disorder and other neurodevelopmental disorders.
Argus Cognitive's top competitors include EMGuidance, PredictImmune and Chkitsak.
Argus Cognitive offers Neurora, Neurora ASD, and Neurora SLP.
Argus Cognitive has 1 investor. Key investors include HHS.